Qingwen Liu

机构：Hunan University, Dalian Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming Medical University, Alibaba Group (United States), Northern Jiangsu People's Hospital, Alibaba Group (China), Ocean University of China · ORCID：0000-0002-1652-8526

发表论文 57 篇 · 总被引 1098 次 · h-index 16

代表论文

• Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses (2024 · ACS Nano · 被引 62)
• Combination of virtual screening, machine learning, molecular dynamics simulations and sensory evaluation to discover novel umami peptides from fermented Atlantic cod (2024 · Food Bioscience · 被引 43)
• Exploiting immunostimulatory mechanisms of immunogenic cell death to develop membrane-encapsulated nanoparticles as a potent tumor vaccine (2023 · Journal of Nanobiotechnology · 被引 30)
• Tumor Vaccine Exploiting Membranes with Influenza Virus-Induced Immunogenic Cell Death to Decorate Polylactic Coglycolic Acid Nanoparticles (2025 · ACS Nano · 被引 24)
• A personalized vaccine combining immunogenic cell death-induced cells and nanosized antigens for enhanced antitumor immunity (2024 · Journal of Controlled Release · 被引 15)
• MAKE: Vision-Language Pre-training based Product Retrieval in Taobao Search (2023 · 被引 11)